Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
AlloVir ( (ALVR) ) has issued an update.
AlloVir, Inc. announced that Dr. Diana Brainard has stepped down as Chief Executive Officer and director, with Vikas Sinha taking over as CEO effective December 19, 2024. Sinha, who has extensive experience in executive finance roles within the life sciences industry, is expected to lead the company following the departure of Dr. Brainard, who left with a comprehensive severance package.
More about AlloVir
YTD Price Performance: -33.82%
Average Trading Volume: 341,058
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $51.12M
See more data about ALVR stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue